Stifel Financial Corp Amgen Inc Transaction History

Stifel Financial Corp

$85.8 Billion
Q1 2024

A detailed history of Stifel Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Stifel Financial Corp holds 1,433,136 shares of AMGN stock, worth $448 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

1,433,136

Previous 1,358,181 5.52%

Holding current value

$448 Million

Previous $391 Million 4.16%

% of portfolio

0.47%

Previous 0.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $20.2 Million - $24.3 Million	74,955 Added 5.52%	1,433,136 $407 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $843,554 - $951,629	3,299 Added 0.24%	1,358,181 $391 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $8.5 Million - $10.6 Million	38,881 Added 2.95%	1,354,882 $364 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $7.14 Million - $8.44 Million	33,325 Added 2.6%	1,316,001 $292 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $59.5 Million - $72.5 Million	263,339 Added 25.83%	1,282,676 $310 Million

Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $5.17 Million - $6.57 Million	22,561 Added 2.26%	1,019,337 $268 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $8.49 Million - $9.57 Million	37,810 Added 3.94%	996,776 $225 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $5.49 Million - $6.11 Million	23,800 Added 2.55%	958,966 $233 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $8.91 Million - $9.86 Million	40,641 Added 4.54%	935,166 $226 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $8.2 Million - $9.38 Million	41,215 Added 4.83%	894,525 $201 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $274,889 - $322,066	1,295 Added 0.15%	853,310 $181 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $6.15 Million - $6.82 Million	26,337 Added 3.19%	852,015 $208 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $9.26 Million - $10.8 Million	41,733 Added 5.32%	825,678 $205 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $6.53 Million - $7.78 Million	30,189 Added 4.01%	783,945 $180 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $9.39 Million - $10.4 Million	40,033 Added 5.61%	753,756 $192 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $8.7 Million - $10.7 Million	43,988 Added 6.57%	713,723 $168 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $21.7 Million - $28.8 Million	-119,150 Reduced 15.1%	669,735 $136 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $42.5 Million - $54.6 Million	224,589 Added 39.8%	788,885 $190 Million
Q3 2019 Nov 19, 2019	SELL	$174.11 - $208.62 $33,080 - $39,637	-190 Reduced 0.03%	564,296 $109 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $10.1 Million - $12.1 Million	-57,905 Reduced 9.3%	564,486 $109 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $14.6 Million - $17.1 Million	87,497 Added 16.36%	622,391 $115 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.27 Million - $1.43 Million	-7,038 Reduced 1.3%	534,894 $102 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.74 Million - $2.03 Million	9,769 Added 1.84%	541,932 $106 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $2.17 Million - $2.44 Million	-11,702 Reduced 2.15%	532,163 $110 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.92 Million - $3.29 Million	17,614 Added 3.35%	543,865 $100 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $9.55 Million - $11.2 Million	-56,351 Reduced 9.67%	526,251 $89.8 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $10.8 Million - $12 Million	-63,888 Reduced 9.88%	582,602 $101 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $106 Million - $121 Million	635,066 Added 5559.05%	646,490 $0
Q2 2017 Nov 01, 2017	BUY	N/A	11,424	11,424 $1.97 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Amgen Inc Transaction History